
|Articles|February 7, 2004
Syndrome X - identification and treatment
Washington D.C. - Stephen E. Chiarello, M.D., began his presentationat the AAD annual meeting yesterday by asking those attending the sessionhow many had heard of Syndrome X. Based on the number of hands raised, hesaid that more dermatologists seem to be aware of this condition, also calledMetabolic Syndrome, which affects 90 million Americans and finds its rootsin high glycerin and insulin levels.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















